181 related articles for article (PubMed ID: 20097856)
1. Activation of ExoU phospholipase activity requires specific C-terminal regions.
Schmalzer KM; Benson MA; Frank DW
J Bacteriol; 2010 Apr; 192(7):1801-12. PubMed ID: 20097856
[TBL] [Abstract][Full Text] [Related]
2. Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU.
Sato H; Feix JB; Frank DW
Biochemistry; 2006 Aug; 45(34):10368-75. PubMed ID: 16922513
[TBL] [Abstract][Full Text] [Related]
3. Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.
Veesenmeyer JL; Howell H; Halavaty AS; Ahrens S; Anderson WF; Hauser AR
Infect Immun; 2010 Aug; 78(8):3346-57. PubMed ID: 20479080
[TBL] [Abstract][Full Text] [Related]
4. Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.
Benson MA; Komas SM; Schmalzer KM; Casey MS; Frank DW; Feix JB
Biophys J; 2011 Mar; 100(5):1335-43. PubMed ID: 21354407
[TBL] [Abstract][Full Text] [Related]
5. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.
Rabin SD; Hauser AR
Infect Immun; 2005 Jan; 73(1):573-82. PubMed ID: 15618197
[TBL] [Abstract][Full Text] [Related]
6. A novel phosphatidylinositol 4,5-bisphosphate binding domain mediates plasma membrane localization of ExoU and other patatin-like phospholipases.
Tyson GH; Halavaty AS; Kim H; Geissler B; Agard M; Satchell KJ; Cho W; Anderson WF; Hauser AR
J Biol Chem; 2015 Jan; 290(5):2919-37. PubMed ID: 25505182
[TBL] [Abstract][Full Text] [Related]
7. ExoU is a potent intracellular phospholipase.
Sato H; Frank DW
Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.
Anderson DM; Schmalzer KM; Sato H; Casey M; Terhune SS; Haas AL; Feix JB; Frank DW
Mol Microbiol; 2011 Dec; 82(6):1454-67. PubMed ID: 22040088
[TBL] [Abstract][Full Text] [Related]
9. Interactions of the effector ExoU from
Springer TI; Reid TE; Gies SL; Feix JB
J Biol Chem; 2019 Dec; 294(50):19012-19021. PubMed ID: 31662432
[No Abstract] [Full Text] [Related]
10. Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.
Feix JB; Kohn S; Tessmer MH; Anderson DM; Frank DW
Cell Biochem Biophys; 2019 Mar; 77(1):79-87. PubMed ID: 30047043
[TBL] [Abstract][Full Text] [Related]
11. Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.
Anderson DM; Feix JB; Monroe AL; Peterson FC; Volkman BF; Haas AL; Frank DW
J Biol Chem; 2013 Sep; 288(37):26741-52. PubMed ID: 23908356
[TBL] [Abstract][Full Text] [Related]
12. Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A
Tessmer MH; Anderson DM; Buchaklian A; Frank DW; Feix JB
J Biol Chem; 2017 Feb; 292(8):3411-3419. PubMed ID: 28069812
[TBL] [Abstract][Full Text] [Related]
13. Intoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbing.
Sato H; Frank DW
PLoS One; 2014; 9(7):e103127. PubMed ID: 25061861
[TBL] [Abstract][Full Text] [Related]
14. Phosphatidylinositol 4,5-Bisphosphate-Dependent Oligomerization of the Pseudomonas aeruginosa Cytotoxin ExoU.
Zhang A; Veesenmeyer JL; Hauser AR
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 28993456
[TBL] [Abstract][Full Text] [Related]
15. A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity.
Benson MA; Schmalzer KM; Frank DW
Clin Chim Acta; 2010 Feb; 411(3-4):190-7. PubMed ID: 19900431
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
[TBL] [Abstract][Full Text] [Related]
17. Traversal of multilayered corneal epithelia by cytotoxic Pseudomonas aeruginosa requires the phospholipase domain of exoU.
Ramirez JC; Fleiszig SM; Sullivan AB; Tam C; Borazjani R; Evans DJ
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):448-53. PubMed ID: 22167094
[TBL] [Abstract][Full Text] [Related]
18. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
[TBL] [Abstract][Full Text] [Related]
19. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 4,5-bisphosphate is a novel coactivator of the Pseudomonas aeruginosa cytotoxin ExoU.
Tyson GH; Hauser AR
Infect Immun; 2013 Aug; 81(8):2873-81. PubMed ID: 23716613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
